Drug – bio-affecting and body treating compositions – Conjugate or complex of monoclonal or polyclonal antibody,... – Conjugated via claimed linking group – bond – chelating agent,...
Patent
1974-05-23
1976-09-07
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Conjugate or complex of monoclonal or polyclonal antibody,...
Conjugated via claimed linking group, bond, chelating agent,...
424180, A61K 3171
Patent
active
039795110
ABSTRACT:
A method of inhibiting the activity of reverse transcriptase in Rous sarcoma viruses and other viruses containing reverse transcriptase. The method comprises subjecting the reverse transcriptase to an enzyme inhibiting effective dosage of a compound of the formula: ##SPC1##
Wherein R' is hydrogen or hydroxyl and R is C.sub.1 -C.sub.8 alkyl, cyclohexyl, phenyl, benzyl, and substituted benzyl.
REFERENCES:
patent: 3681326 (1972-08-01), Von Esch
Hung Paul P.
Shipkowitz Nathan L.
Von Esch Anne Mary
Abbott Laboratories
Goldberg Jerome D.
Mallare Vincent A.
Niblack Robert L.
LandOfFree
Inhibitors of reverse transcriptase enzymes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of reverse transcriptase enzymes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of reverse transcriptase enzymes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2173390